那位好心人能帮我翻译一下这篇文章么

With China's accession to the WTO, the pharmaceutical industry is facing both development opportunities and severe challenges. At present, drug distribution services, domestic pharmaceutical production and operation of enterprises to face international competition rivals.
In recent years, domestic pharmacies and the growing number of the growing scale, and even the involvement of foreign chain to the pharmacy business and has brought increasing competition. Merciless price war, the gross margin increase, the majority of pharmacy costs rise instead of falling. However, after several years of growth and development of the course, the well-known brand pharmaceuticals small enterprises.

With the entering of WTO, the pharmaceutical sector is facing both chances, and fierce challenge. Now, in the field of pharmaceutical distribution service, national producers and sellers have to face international challenges directly.

Recently, the amount and scale of national pharmacies is becoming larger and larger. And the interposition of foreign-investment brings even harsher competition. The net profit rate that rises with the fierce price competition makes the cost even lower. Many years of developing elapsed, however, outstanding pharmaceutical brands are still rare and hard to find.

一楼翻译的相当好，非常的佩服！